Evidence map›Paper›PMID 29296190›Full record

ArticleOncotarget2017

Expression characteristics of the plasmid-borne

Haifang Zhang, Minhui Miao, Jieting Yan, Min Wang, Yi-Wei Tang, Barry N Kreiswirth, Xia Zhang, Liang Chen, Hong Du

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Integrated Genomic and Phenotypic Characterization of anTransboundary and emerging diseases · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Characterisation of Early PositiveAntibiotics (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in public health · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. AFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haifang Zhang *Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
Minhui Miao *Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
Jieting Yan *Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
Min WangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
Yi-Wei TangDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York 10065, USA.
Barry N KreiswirthPublic Health Research Institute TB Center, Rutgers University, Newark, New Jersey 07103, USA.
Xia ZhangDepartment of Clinical Laboratory, The North District of Affiliated Suzhou Hospital, Nanjing Medical University, Suzhou 215008, Jiangsu Province, China.
Liang ChenPublic Health Research Institute TB Center, Rutgers University, Newark, New Jersey 07103, USA.
Hong DuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.

Funding

Genomic variation in epidemic carbapenem-resistant K.pneumoniaeR21AI117338 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI CHEN, LIANG · 2016 to 2017
$437k
NIAID NIH HHS R21 AI117338
6 · The paper itself

Abstract

The plasmid-encoded colistin resistance gene (

Indexed as

colistingene expressionmcr-1plasmidregulation

Identifiers

PMID29296190
PMCPMC5746092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.